On the Path toward Classifying Hormones of the Vasoinhibin-Family.
作者信息
Triebel Jakob, Bertsch Thomas, Martínez de la Escalera Gonzalo, Clapp Carmen
机构信息
Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University , Nuremberg , Germany.
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla , Querétaro , México.
出版信息
Front Endocrinol (Lausanne). 2015 Feb 10;6:16. doi: 10.3389/fendo.2015.00016. eCollection 2015.
Abstract
摘要
相似文献
1
On the Path toward Classifying Hormones of the Vasoinhibin-Family.
Front Endocrinol (Lausanne). 2015 Feb 10;6:16. doi: 10.3389/fendo.2015.00016. eCollection 2015.
2
From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.
Front Endocrinol (Lausanne). 2017 Dec 11;8:342. doi: 10.3389/fendo.2017.00342. eCollection 2017.
3
Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors.
Psychoneuroendocrinology. 2014 Jun;44:123-32. doi: 10.1016/j.psyneuen.2014.03.006. Epub 2014 Mar 21.
4
Principles of the prolactin/vasoinhibin axis.
Am J Physiol Regul Integr Comp Physiol. 2015 Nov 15;309(10):R1193-203. doi: 10.1152/ajpregu.00256.2015. Epub 2015 Aug 26.
5
Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.
Front Endocrinol (Lausanne). 2017 Nov 6;8:294. doi: 10.3389/fendo.2017.00294. eCollection 2017.
6
Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules.
Endocrinology. 2009 Dec;150(12):5446-54. doi: 10.1210/en.2009-0390. Epub 2009 Oct 9.
7
Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase.
Front Endocrinol (Lausanne). 2017 May 22;8:105. doi: 10.3389/fendo.2017.00105. eCollection 2017.
8
A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia.
Front Endocrinol (Lausanne). 2020 Jan 9;10:893. doi: 10.3389/fendo.2019.00893. eCollection 2019.
9
Vasoinhibins May Contribute to Postpartum Depression.
Front Psychiatry. 2017 Sep 12;8:167. doi: 10.3389/fpsyt.2017.00167. eCollection 2017.
10
Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability.
Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8944-50. doi: 10.1167/iovs.11-8190.
引用本文的文献
1
The 14-Kilodalton Human Growth Hormone Fragment a Potent Inhibitor of Angiogenesis and Tumor Metastasis.
Int J Mol Sci. 2023 May 17;24(10):8877. doi: 10.3390/ijms24108877.
2
Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.
Front Endocrinol (Lausanne). 2022 Sep 9;13:994898. doi: 10.3389/fendo.2022.994898. eCollection 2022.
3
Regulator of Angiogenesis and Vascular Function: A 2019 Update of the Vasoinhibin Nomenclature.
Front Endocrinol (Lausanne). 2019 Apr 10;10:214. doi: 10.3389/fendo.2019.00214. eCollection 2019.
4
From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.
Front Endocrinol (Lausanne). 2017 Dec 11;8:342. doi: 10.3389/fendo.2017.00342. eCollection 2017.
5
Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.
Front Endocrinol (Lausanne). 2017 Nov 6;8:294. doi: 10.3389/fendo.2017.00294. eCollection 2017.
6
Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy.
Front Endocrinol (Lausanne). 2017 Apr 11;8:77. doi: 10.3389/fendo.2017.00077. eCollection 2017.
7
Principles of the prolactin/vasoinhibin axis.
Am J Physiol Regul Integr Comp Physiol. 2015 Nov 15;309(10):R1193-203. doi: 10.1152/ajpregu.00256.2015. Epub 2015 Aug 26.
本文引用的文献
1
Pathophysiology and epidemiology of peripartum cardiomyopathy.
Nat Rev Cardiol. 2014 Jun;11(6):364-70. doi: 10.1038/nrcardio.2014.37. Epub 2014 Apr 1.
2
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
J Clin Invest. 2013 May;123(5):2143-54. doi: 10.1172/JCI64365. Epub 2013 Apr 24.
3
Novel fusion protein derived from vasostatin 30 and vasoinhibin II-14.1 potently inhibits coronary endothelial cell proliferation.
Mol Biotechnol. 2013 Jul;54(3):920-9. doi: 10.1007/s12033-012-9642-4.
4
The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.
PLoS One. 2011;6(11):e27318. doi: 10.1371/journal.pone.0027318. Epub 2011 Nov 7.
5
Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy.
IUBMB Life. 2011 Oct;63(10):806-10. doi: 10.1002/iub.518. Epub 2011 Sep 13.
6
High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins.
Diabetes. 2010 Dec;59(12):3192-7. doi: 10.2337/db10-0873. Epub 2010 Sep 7.
7
Peptide hormone regulation of angiogenesis.
Physiol Rev. 2009 Oct;89(4):1177-215. doi: 10.1152/physrev.00024.2009.
8
Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth.
Cancer Lett. 2009 Nov 1;284(2):222-8. doi: 10.1016/j.canlet.2009.04.030. Epub 2009 May 26.
9
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
Cell. 2007 Feb 9;128(3):589-600. doi: 10.1016/j.cell.2006.12.036.
10
Vasoinhibins: endogenous regulators of angiogenesis and vascular function.
Trends Endocrinol Metab. 2006 Oct;17(8):301-7. doi: 10.1016/j.tem.2006.08.002. Epub 2006 Aug 23.
Zotero 插件